-
2023-507518-28-00
5
2022-09-13
Acute myeloid leukemia
-
2024-516066-11-00
5
2022-08-31
Patients with newly diagnosed, histologically confirmed, primary advan
-
2024-512119-34-00
4
2022-06-20
MSI-H/dMMR metastatic colorectal cancer
-
2023-506414-46-00
5
2022-04-22
High risk patients defined as having at least one of the following ris
-
2023-505749-14-00
5
2022-03-20
c-Met overexpressing EGFR wildtype non-squamous non-small cell lung ca
-
2024-514617-35-00
4
2021-12-20
Progressive forms of Multiple Sclerosis
-
2022-501677-39-00
5
2021-05-25
Adolescent Renal Allografts
-
2023-506471-10-00
5
2019-10-04
Secondary hyperparathyroidism (SHPT) in pediatric patients with chroni
-
2023-505060-11-00
3
2019-06-19
Polyarticular Course Juvenile Idiopathic Arthritis
-
2023-508587-29-00
4
2018-04-03
Treatment of high-risk neuroblastoma patients with primary refractory
-
2024-512358-78-00
7
2015-01-20
Solid Tumors
-
2024-512657-24-00
10
2014-03-27
Acute Lymphoblastic Leukaemia
-
2025-524580-21-00
10
2026-06-01
Grass pollen induced allergic rhinitis or rhinoconjunctivitis
-
2025-522091-84-00
4
2026-05-29
Merkel Cell Carcinoma
-
2024-517337-41-00
5
2026-05-12
Completely resected Stage IIA-IIIB (N2) KRAS G12C mutated NSCLC
-
2025-523975-48-00
5
2026-05-08
Obesity
-
2023-509628-16-00
5
2026-05-07
Small Cell Lung Cancer (SCLC)
-
2025-523123-22-00
5
2026-05-07
Chronic Kidney Disease
-
2024-520443-16-00
5
2026-05-04
Overweight or obesity, and obstructive sleep apnoea treated with posit
-
2024-520442-36-00
5
2026-04-30
Overweight or obesity, and obstructive sleep apnoea not treated with p
-
2025-523914-10-00
6
2026-04-30
Critical illness
-
2025-523974-18-00
5
2026-04-30
Obesity
-
2022-501458-13-01
4
2026-04-29
Advanced Stage of Classic Hodgkin Lymphoma
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity